NCT03003520 2023-05-22A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell LymphomaCelgenePhase 2 Completed46 enrolled 20 charts
NCT00002757 2014-07-24TITLE:Less Intensive Therapy for Children With Non-Hodgkin's LymphomaChildren's Oncology GroupPhase 3 Completed1,148 enrolled